These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 25633745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS, Kong PZ, Li XQ, Yang F, Feng YM.
    Breast Cancer Res; 2015 Feb 26; 17(1):30. PubMed ID: 25848863
    [Abstract] [Full Text] [Related]

  • 4. A novel 2-pyrone derivative, BHP, impedes oncogenic KRAS-driven malignant progression in breast cancer.
    Kim RK, Suh Y, Lim EJ, Yoo KC, Lee GH, Cui YH, Son A, Hwang E, Uddin N, Yi JM, Kang SG, Lee SJ.
    Cancer Lett; 2013 Aug 28; 337(1):49-57. PubMed ID: 23707634
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
    Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D.
    Sci Signal; 2011 Jun 14; 4(177):ra41. PubMed ID: 21673316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies.
    Steckel M, Molina-Arcas M, Weigelt B, Marani M, Warne PH, Kuznetsov H, Kelly G, Saunders B, Howell M, Downward J, Hancock DC.
    Cell Res; 2012 Aug 14; 22(8):1227-45. PubMed ID: 22613949
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
    Bendinelli P, Matteucci E, Maroni P, Desiderio MA.
    Mol Cancer Res; 2009 Aug 14; 7(8):1328-41. PubMed ID: 19671685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.
    Li H, Chen X, Gao Y, Wu J, Zeng F, Song F.
    Cell Signal; 2015 Jan 14; 27(1):82-9. PubMed ID: 25280941
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
    Huo X, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y.
    Oncotarget; 2015 Dec 08; 6(39):41959-75. PubMed ID: 26544623
    [Abstract] [Full Text] [Related]

  • 19. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D.
    Sci Signal; 2011 Aug 09; 4(186):pt5. PubMed ID: 21868360
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.